| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC26A9 SLCO1B1 SLCO6A1 SLC18B1 SLC4A3 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC17A9 SLC18A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 1.09e-19 | 296 | 102 | 22 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLCO1B1 SLCO6A1 SLC18B1 SLC4A3 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC17A9 SLC18A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 1.19e-18 | 477 | 102 | 25 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 SFXN4 SPNS1 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLCO1B1 SLCO6A1 SLC18B1 SLC4A3 SLC25A51 CHRNA5 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 SLC16A3 CLCNKB SLC17A9 SLC18A3 CLDN17 SLC20A2 SLC6A20 SFXN2 SLC47A1 SLC2A13 SEC63 SLC16A7 | 2.87e-17 | 1180 | 102 | 34 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 SFXN4 SPNS1 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLCO1B1 SLCO6A1 SLC18B1 SLC4A3 SLC25A51 CHRNA5 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 SLC16A3 CLCNKB SLC17A9 SLC18A3 CLDN17 SLC20A2 NPC1L1 SLC6A20 SFXN2 SLC47A1 SLC2A13 SEC63 SLC16A7 | 5.35e-17 | 1289 | 102 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A6 ATP6V0A1 ATP7B SLC26A9 SLC18B1 SLC4A3 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC18A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 | 1.41e-14 | 301 | 102 | 18 | GO:0022853 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 SFXN4 ATP6V0A1 ATP7B SLC26A9 SLC18B1 SLC4A3 CHRNA5 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 SLC16A3 CLCNKB SLC18A3 CLDN17 SLC20A2 SLC6A20 SFXN2 SLC47A1 SLC2A13 | 1.22e-12 | 793 | 102 | 24 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P OR5K3 OPN1SW F2RL1 CRHR1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 ADGRE3 OR7D2 OR52M1 ADGRE1 | 1.69e-12 | 884 | 102 | 25 | GO:0004930 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A6 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC20A2 SLC6A20 SLC2A13 SLC16A7 | 1.57e-11 | 150 | 102 | 12 | GO:0015293 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A6 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC20A2 SLC6A20 SLC2A13 | 2.38e-11 | 119 | 102 | 11 | GO:0015294 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC5 SLC26A9 SLCO1B1 SLCO6A1 SLC4A3 SLCO1B7 SLC7A8 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC17A9 SLC6A20 SLC47A1 SLC16A7 | 2.44e-11 | 293 | 102 | 15 | GO:0008514 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLC18B1 SLC4A3 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 SLC16A3 CLCNKB SLC18A3 CLDN17 SLC20A2 SLC6A20 SLC47A1 SLC2A13 | 2.80e-11 | 758 | 102 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P OR5K3 OPN1SW F2RL1 CHRNA5 CRHR1 GFRA3 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 ADGRE3 OR7D2 SCARB2 OR52M1 ADGRE1 | 1.01e-10 | 1353 | 102 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | SLCO1B1 SLCO1B7 SLC6A3 SLC6A4 SLC10A1 SLC16A3 SLC2A13 SLC16A7 | 2.55e-09 | 70 | 102 | 8 | GO:1901618 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 5.07e-09 | 431 | 102 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 ATP6V0A1 ATP7B SLC18B1 CHRNA5 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 SLC16A3 SLC18A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 | 6.57e-09 | 664 | 102 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC26A9 SLCO1B1 SLCO1B7 SLC7A8 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC6A20 SLC47A1 SLC16A7 | 8.90e-09 | 207 | 102 | 11 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC26A9 SLCO1B1 SLCO1B7 SLC7A8 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC6A20 SLC47A1 SLC16A7 | 9.36e-09 | 208 | 102 | 11 | GO:0005342 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC12A6 ABCC5 SLC26A9 SLC4A3 SLC12A5 SLC6A3 SLC6A4 CLCNKB CLDN17 SLC20A2 | 1.76e-08 | 171 | 102 | 10 | GO:0015103 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 ATP6V0A1 ATP7B SLC18B1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 SLC16A3 SLC18A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 | 1.81e-08 | 627 | 102 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.23e-07 | 83 | 102 | 7 | GO:0015101 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.52e-07 | 125 | 102 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 3.08e-07 | 12 | 102 | 4 | GO:0008504 | |
| GeneOntologyMolecularFunction | antiporter activity | SLC26A9 SLC18B1 SLC4A3 SLC7A8 SLC6A4 SLC32A1 SLC18A3 SLC47A1 | 5.39e-07 | 138 | 102 | 8 | GO:0015297 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.07e-06 | 151 | 102 | 8 | GO:0008509 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.34e-06 | 19 | 102 | 4 | GO:0015355 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.65e-06 | 81 | 102 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 5.27e-06 | 23 | 102 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 6.74e-06 | 90 | 102 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 8.80e-06 | 26 | 102 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.79e-05 | 171 | 102 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 3.14e-05 | 71 | 102 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 5.10e-05 | 188 | 102 | 7 | GO:0015078 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 5.62e-05 | 41 | 102 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 6.19e-05 | 42 | 102 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 6.90e-05 | 16 | 102 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 9.99e-05 | 18 | 102 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 ATP7B SLC12A5 SLC6A3 SLC6A4 SLC6A7 SLC10A1 TRPM5 SLC20A2 SLC6A20 | 1.34e-04 | 465 | 102 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | monoamine:proton antiporter activity | 1.54e-04 | 4 | 102 | 2 | GO:0015311 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 1.61e-04 | 21 | 102 | 3 | GO:0005326 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.03e-04 | 105 | 102 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | proline:sodium symporter activity | 2.56e-04 | 5 | 102 | 2 | GO:0005298 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.74e-04 | 25 | 102 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | lactate transmembrane transporter activity | 3.82e-04 | 6 | 102 | 2 | GO:0015129 | |
| GeneOntologyMolecularFunction | pyruvate transmembrane transporter activity | 3.82e-04 | 6 | 102 | 2 | GO:0050833 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.29e-04 | 29 | 102 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 4.29e-04 | 29 | 102 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 5.34e-04 | 7 | 102 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 6.32e-04 | 33 | 102 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 6.90e-04 | 34 | 102 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 7.52e-04 | 35 | 102 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 9.09e-04 | 9 | 102 | 2 | GO:0015349 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 9.09e-04 | 9 | 102 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.03e-03 | 39 | 102 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | branched-chain amino acid transmembrane transporter activity | 1.13e-03 | 10 | 102 | 2 | GO:0015658 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 1.13e-03 | 10 | 102 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.38e-03 | 43 | 102 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.38e-03 | 11 | 102 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.65e-03 | 12 | 102 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.94e-03 | 13 | 102 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.94e-03 | 13 | 102 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 2.26e-03 | 14 | 102 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.60e-03 | 15 | 102 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 3.34e-03 | 17 | 102 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.42e-03 | 59 | 102 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.76e-03 | 61 | 102 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | odorant binding | 4.10e-03 | 127 | 102 | 4 | GO:0005549 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 4.17e-03 | 19 | 102 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | amine binding | 5.09e-03 | 21 | 102 | 2 | GO:0043176 | |
| GeneOntologyMolecularFunction | channel activity | 5.48e-03 | 525 | 102 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.54e-03 | 526 | 102 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.10e-03 | 23 | 102 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.21e-03 | 73 | 102 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 7.75e-03 | 26 | 102 | 2 | GO:0000295 | |
| GeneOntologyMolecularFunction | virus receptor activity | 9.44e-03 | 85 | 102 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 9.75e-03 | 86 | 102 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | chloride channel activity | 9.75e-03 | 86 | 102 | 3 | GO:0005254 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 TAAR3P OR5K3 OR4K14 OR9G9 OR1N2 SLC6A3 OR2K2 OR52A5 OR7D2 OR52M1 | 1.55e-10 | 547 | 101 | 18 | GO:0007606 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 SFXN4 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLCO1B1 SLC18B1 SLC4A3 CHRNA5 CRHR1 SLC12A5 SLCO1B7 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 CLCNKB MTOR SLC18A3 CLDN17 SLC20A2 SLC6A20 SFXN2 SLC47A1 | 2.89e-10 | 1374 | 101 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 SFXN4 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLC18B1 SLC4A3 CHRNA5 CRHR1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 TRPM5 CLCNKB MTOR SLC18A3 CLDN17 SLC20A2 SLC6A20 SFXN2 SLC47A1 | 5.81e-10 | 1115 | 101 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 SLC6A3 OR2K2 OR52A5 OR7D2 OR52M1 | 9.50e-10 | 465 | 101 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P DGKG OR5K3 OPN1SW F2RL1 CRHR1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 ADGRE3 OR7D2 OR52M1 ADGRE1 | 2.06e-09 | 1395 | 101 | 26 | GO:0007186 |
| GeneOntologyBiologicalProcess | organic cation transport | SLC18B1 PTGS1 CRHR1 SLC6A3 SLC7A8 SLC32A1 SLC18A3 SLC6A20 SFXN2 SLC47A1 | 2.40e-09 | 145 | 101 | 10 | GO:0015695 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 2.96e-09 | 432 | 101 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC5 SLC26A9 SLCO1B1 SLCO6A1 SLC4A3 SLCO1B7 SLC7A8 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC17A9 SLC6A20 SFXN2 SLC47A1 SLC16A7 | 4.10e-09 | 515 | 101 | 16 | GO:0015711 |
| GeneOntologyBiologicalProcess | sensory perception | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 TAAR3P OR5K3 OPN1SW CHRNA5 OR4K14 OR9G9 OR1N2 SLC6A3 OR2K2 OR52A5 OR7D2 SCARB2 OR52M1 MYO15A | 8.31e-09 | 1072 | 101 | 22 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 1.40e-08 | 485 | 101 | 15 | GO:0050907 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLC18B1 SLC4A3 CRHR1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 TRPM5 CLCNKB MTOR SLC18A3 CLDN17 SLC20A2 SLC6A20 SLC47A1 | 1.74e-08 | 1017 | 101 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | SLCO1B1 SLC18B1 PTGS1 CRHR1 SLCO1B7 SLC6A3 SLC6A4 SLC10A1 SLC16A3 SLC18A3 NPC1L1 SLC2A13 SLC16A7 | 2.15e-08 | 358 | 101 | 13 | GO:0015850 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 CHRNA5 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 2.29e-08 | 582 | 101 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 3.88e-08 | 524 | 101 | 15 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OPN1SW CHRNA5 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 7.56e-08 | 722 | 101 | 17 | GO:0051606 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC5 SLC26A9 SLCO1B1 SLCO1B7 SLC7A8 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC6A20 SFXN2 SLC47A1 SLC16A7 | 1.05e-07 | 410 | 101 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ABCC5 SLC26A9 SLCO1B1 SLCO1B7 SLC7A8 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC6A20 SFXN2 SLC47A1 SLC16A7 | 1.11e-07 | 412 | 101 | 13 | GO:0015849 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 3.13e-07 | 134 | 101 | 8 | GO:0098661 | |
| GeneOntologyBiologicalProcess | amino acid transport | SFXN4 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC6A20 SFXN2 SLC47A1 | 4.95e-07 | 195 | 101 | 9 | GO:0006865 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.60e-07 | 153 | 101 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.39e-06 | 163 | 101 | 8 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.66e-06 | 167 | 101 | 8 | GO:1903825 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.91e-06 | 180 | 101 | 8 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.30e-06 | 183 | 101 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 4.35e-06 | 87 | 101 | 6 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 4.65e-06 | 88 | 101 | 6 | GO:0010232 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC18B1 CRHR1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 TRPM5 SLC18A3 SLC20A2 SLC6A20 SLC47A1 | 1.01e-05 | 922 | 101 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.12e-05 | 60 | 101 | 5 | GO:0015804 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC12A6 LAMA2 CHRNA5 CRHR1 CCKBR SLC12A5 SLC6A3 SLC6A4 SLC32A1 PTCHD1 BRAF MTOR SLC18A3 PRKCG RIC3 SEZ6 | 1.14e-05 | 931 | 101 | 16 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC12A6 LAMA2 CHRNA5 CRHR1 CCKBR SLC12A5 SLC6A3 SLC6A4 SLC32A1 PTCHD1 BRAF MTOR SLC18A3 PRKCG RIC3 SEZ6 | 1.14e-05 | 931 | 101 | 16 | GO:0007268 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC18B1 CRHR1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 CLCNKB SLC18A3 SLC20A2 SLC6A20 SLC47A1 | 1.18e-05 | 1157 | 101 | 18 | GO:0006812 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SLC12A6 LAMA2 CHRNA5 CRHR1 CCKBR SLC12A5 SLC6A3 SLC6A4 SLC32A1 PTCHD1 BRAF MTOR SLC18A3 PRKCG RIC3 SEZ6 | 1.26e-05 | 939 | 101 | 16 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC18B1 CRHR1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 TRPM5 SLC18A3 SLC20A2 SLC6A20 SLC47A1 | 1.31e-05 | 942 | 101 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | proline transmembrane transport | 1.83e-05 | 11 | 101 | 3 | GO:0035524 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.87e-05 | 112 | 101 | 6 | GO:1902476 | |
| GeneOntologyBiologicalProcess | synaptic signaling | SLC12A6 LAMA2 CHRNA5 CRHR1 CCKBR SLC12A5 SLC6A3 SLC6A4 SLC32A1 PTCHD1 BRAF MTOR SLC18A3 PRKCG RIC3 SEZ6 | 2.03e-05 | 976 | 101 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | monoamine transport | 2.28e-05 | 116 | 101 | 6 | GO:0015844 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 2.76e-05 | 120 | 101 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | regulation of pH | 2.76e-05 | 120 | 101 | 6 | GO:0006885 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 3.52e-05 | 38 | 101 | 4 | GO:0098810 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.97e-05 | 128 | 101 | 6 | GO:0006821 | |
| GeneOntologyBiologicalProcess | serotonin uptake | 3.99e-05 | 14 | 101 | 3 | GO:0051610 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 4.10e-05 | 259 | 101 | 8 | GO:0006836 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCC5 F2RL1 SLC4A3 PTGS1 SLC7A8 SLC6A4 SLC6A20 SLC2A13 SLC16A7 | 4.88e-05 | 344 | 101 | 9 | GO:0003018 |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 4.97e-05 | 15 | 101 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | glycine transport | 4.97e-05 | 15 | 101 | 3 | GO:0015816 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 6.25e-05 | 275 | 101 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 6.32e-05 | 44 | 101 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 1.22e-04 | 52 | 101 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 1.88e-04 | 58 | 101 | 4 | GO:0089718 | |
| GeneOntologyBiologicalProcess | oligopeptide transport | 1.88e-04 | 23 | 101 | 3 | GO:0006857 | |
| GeneOntologyBiologicalProcess | cognition | 2.33e-04 | 423 | 101 | 9 | GO:0050890 | |
| GeneOntologyBiologicalProcess | plasma membrane lactate transport | 3.52e-04 | 6 | 101 | 2 | GO:0035879 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 3.75e-04 | 125 | 101 | 5 | GO:0043279 | |
| GeneOntologyBiologicalProcess | behavior | PTGS1 CHRNA5 CRHR1 CCKBR SLC12A5 SLC6A3 SLC6A4 PTCHD1 BRAF MTOR PRKCG MYO15A SEZ6 | 4.05e-04 | 891 | 101 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | response to cocaine | 4.09e-04 | 71 | 101 | 4 | GO:0042220 | |
| GeneOntologyBiologicalProcess | pH reduction | 4.91e-04 | 7 | 101 | 2 | GO:0045851 | |
| GeneOntologyBiologicalProcess | pyruvate transmembrane transport | 4.91e-04 | 7 | 101 | 2 | GO:1901475 | |
| GeneOntologyBiologicalProcess | learning or memory | 4.97e-04 | 373 | 101 | 8 | GO:0007611 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 4.99e-04 | 133 | 101 | 5 | GO:0007200 | |
| GeneOntologyBiologicalProcess | serotonin transport | 5.10e-04 | 32 | 101 | 3 | GO:0006837 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 5.60e-04 | 208 | 101 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | learning | 6.19e-04 | 212 | 101 | 6 | GO:0007612 | |
| GeneOntologyBiologicalProcess | import into cell | SLC12A6 F2RL1 SLC18B1 SLC12A5 SLC6A3 SLC7A8 SLC6A4 SLC6A7 SLC18A3 SCARB2 SLC6A20 SLC47A1 PRKCG MYO15A | 7.36e-04 | 1074 | 101 | 14 | GO:0098657 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 8.24e-04 | 224 | 101 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | pyruvate transport | 8.36e-04 | 9 | 101 | 2 | GO:0006848 | |
| GeneOntologyBiologicalProcess | lactate transport | 8.36e-04 | 9 | 101 | 2 | GO:0015727 | |
| GeneOntologyBiologicalProcess | lactate transmembrane transport | 8.36e-04 | 9 | 101 | 2 | GO:0035873 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 9.45e-04 | 230 | 101 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.01e-03 | 233 | 101 | 6 | GO:0050806 | |
| GeneOntologyBiologicalProcess | negative regulation of epinephrine secretion | 1.04e-03 | 10 | 101 | 2 | GO:0032811 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 1.14e-03 | 42 | 101 | 3 | GO:0051503 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 1.18e-03 | 94 | 101 | 4 | GO:0051453 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 ATP7B ABCC5 CRHR1 SLC12A5 SLC6A3 SLC6A4 SLC6A7 SLC10A1 TRPM5 CLCNKB SLC20A2 SLC6A20 | 1.18e-03 | 1000 | 101 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.21e-03 | 162 | 101 | 5 | GO:0015748 | |
| GeneOntologyBiologicalProcess | neurotransmitter loading into synaptic vesicle | 1.27e-03 | 11 | 101 | 2 | GO:0098700 | |
| GeneOntologyBiologicalProcess | guanine nucleotide transport | 1.27e-03 | 11 | 101 | 2 | GO:0001408 | |
| GeneOntologyBiologicalProcess | regulation of epinephrine secretion | 1.27e-03 | 11 | 101 | 2 | GO:0014060 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.30e-03 | 44 | 101 | 3 | GO:0015865 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 1.50e-03 | 170 | 101 | 5 | GO:1902600 | |
| GeneOntologyBiologicalProcess | regulation of lysosome organization | 1.52e-03 | 12 | 101 | 2 | GO:1905671 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, cholinergic | 1.52e-03 | 12 | 101 | 2 | GO:0032224 | |
| GeneOntologyBiologicalProcess | bile acid signaling pathway | 1.52e-03 | 12 | 101 | 2 | GO:0038183 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.54e-03 | 101 | 101 | 4 | GO:0030641 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.58e-03 | 47 | 101 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | thyroid hormone transport | 1.79e-03 | 13 | 101 | 2 | GO:0070327 | |
| GeneOntologyBiologicalProcess | epinephrine secretion | 1.79e-03 | 13 | 101 | 2 | GO:0048242 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 1.79e-03 | 13 | 101 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | proline transport | 1.79e-03 | 13 | 101 | 2 | GO:0015824 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 1.89e-03 | 50 | 101 | 3 | GO:0006862 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.97e-03 | 108 | 101 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | response to pain | 2.00e-03 | 51 | 101 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | memory | 2.07e-03 | 183 | 101 | 5 | GO:0007613 | |
| GeneOntologyBiologicalProcess | hypotonic response | 2.08e-03 | 14 | 101 | 2 | GO:0006971 | |
| GeneOntologyBiologicalProcess | branched-chain amino acid transport | 2.08e-03 | 14 | 101 | 2 | GO:0015803 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC12A6 ATP7B C5AR2 ABCC5 SLCO1B1 SLCO6A1 SLCO1B7 SLC7A8 SLC10A1 SLC16A3 SLC47A1 SLC16A7 | 1.59e-07 | 354 | 102 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | SLC12A6 ATP7B C5AR2 ABCC5 SLCO1B1 SLCO6A1 SLCO1B7 SLC7A8 SLC10A1 SLC16A3 SLC47A1 SLC16A7 | 3.21e-07 | 378 | 102 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC12A6 ATP7B ABCC5 SLCO1B1 SLCO6A1 SLCO1B7 SLC7A8 SLC10A1 SLC16A3 SLC47A1 SLC16A7 | 4.70e-07 | 320 | 102 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | apical part of cell | SLC12A6 ATP7B C5AR2 ABCC5 SLC26A9 CRHR1 SLC7A8 SLC16A3 SLC20A2 NPC1L1 SLC6A20 SLC47A1 SLC2A13 | 6.15e-06 | 592 | 102 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC12A6 ABCC5 SLC26A9 SLC7A8 SLC16A3 SLC20A2 NPC1L1 SLC6A20 SLC47A1 SLC2A13 | 1.35e-04 | 487 | 102 | 10 | GO:0016324 |
| MousePheno | abnormal behavioral response to xenobiotic | SLC12A6 SLC4A3 CHRNA5 CRHR1 CCKBR SLC12A5 SLC6A3 SLC7A8 SLC6A4 SLC18A3 PRKCG SEZ6 | 7.09e-08 | 309 | 74 | 12 | MP:0009745 |
| MousePheno | abnormal seizure response to inducing agent | 1.06e-05 | 201 | 74 | 8 | MP:0009357 | |
| MousePheno | abnormal seizure response to pharmacological agent | 1.23e-05 | 147 | 74 | 7 | MP:0000950 | |
| MousePheno | abnormal xenobiotic pharmacokinetics | 1.79e-05 | 30 | 74 | 4 | MP:0008875 | |
| MousePheno | abnormal muscle tone | 2.91e-05 | 68 | 74 | 5 | MP:0004142 | |
| MousePheno | abnormal nervous system electrophysiology | SLC12A6 LAMA2 DGKG SLC12A5 SLC6A3 SLC6A4 SLC32A1 PTCHD1 SLC16A3 | 5.72e-05 | 329 | 74 | 9 | MP:0002272 |
| MousePheno | abnormal hearing electrophysiology | SLC12A6 LAMA2 PTGS1 SLC7A8 PTCHD1 PCNX4 SLC20A2 SCARB2 MED25 PRMT9 RELL1 MYO15A | 6.09e-05 | 594 | 74 | 12 | MP:0006335 |
| MousePheno | abnormal gallbladder physiology | 6.32e-05 | 41 | 74 | 4 | MP:0005085 | |
| MousePheno | abnormal stria vascularis morphology | 8.37e-05 | 44 | 74 | 4 | MP:0000048 | |
| MousePheno | seizures | SLC12A6 SLC4A3 CHRNA5 SLC12A5 SLC7A8 SLC32A1 BRAF SLC18A3 SEZ6 | 1.14e-04 | 360 | 74 | 9 | MP:0002064 |
| MousePheno | decreased physiological sensitivity to xenobiotic | 1.21e-04 | 283 | 74 | 8 | MP:0008874 | |
| MousePheno | abnormal hearing physiology | SLC12A6 LAMA2 PTGS1 SLC7A8 PTCHD1 PCNX4 SLC20A2 SCARB2 MED25 PRMT9 RELL1 MYO15A | 1.30e-04 | 643 | 74 | 12 | MP:0001963 |
| MousePheno | abnormal stomach pH | 1.30e-04 | 19 | 74 | 3 | MP:0008004 | |
| MousePheno | abnormal motor coordination/balance | SLC12A6 ATP6V0A1 ATP7B LAMA2 DGKG CCKBR SLC6A3 SLC7A8 SLC18A3 PCNX4 SLC20A2 PRKCG MYO15A SEZ6 | 1.68e-04 | 873 | 74 | 14 | MP:0001516 |
| MousePheno | abnormal drinking behavior | 1.93e-04 | 159 | 74 | 6 | MP:0001422 | |
| MousePheno | abnormal auditory brainstem response | LAMA2 PTGS1 SLC7A8 PTCHD1 PCNX4 SLC20A2 SCARB2 MED25 PRMT9 RELL1 MYO15A | 2.09e-04 | 576 | 74 | 11 | MP:0004738 |
| MousePheno | abnormal ear physiology | SLC12A6 LAMA2 PTGS1 SLC7A8 PTCHD1 PCNX4 SLC20A2 SCARB2 MED25 PRMT9 RELL1 MYO15A | 2.30e-04 | 684 | 74 | 12 | MP:0003878 |
| MousePheno | abnormal urine prostaglandin level | 2.74e-04 | 5 | 74 | 2 | MP:0011562 | |
| MousePheno | cochlear degeneration | 3.20e-04 | 62 | 74 | 4 | MP:0000032 | |
| MousePheno | cochlear ganglion degeneration | 3.40e-04 | 63 | 74 | 4 | MP:0002857 | |
| MousePheno | abnormal circulating bilirubin level | 3.58e-04 | 251 | 74 | 7 | MP:0001569 | |
| MousePheno | hypotonia | 3.80e-04 | 27 | 74 | 3 | MP:0004144 | |
| MousePheno | abnormal synaptic transmission | SLC12A6 SPNS1 ATP6V0A1 LAMA2 DGKG CCKBR SLC12A5 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC18A3 PRKCG RELL1 SEZ6 | 4.11e-04 | 1070 | 74 | 15 | MP:0003635 |
| MousePheno | impaired long-term object recognition memory | 4.24e-04 | 28 | 74 | 3 | MP:0014367 | |
| MousePheno | abnormal synaptic physiology | SLC12A6 SPNS1 ATP6V0A1 LAMA2 DGKG CCKBR SLC12A5 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC18A3 PRKCG RELL1 SEZ6 | 4.36e-04 | 1076 | 74 | 15 | MP:0021009 |
| MousePheno | decreased susceptibility to induction of seizure by inducing agent | 4.71e-04 | 29 | 74 | 3 | MP:0012348 | |
| MousePheno | decreased susceptibility to pharmacologically induced seizures | 4.71e-04 | 29 | 74 | 3 | MP:0002887 | |
| MousePheno | abnormal learning/memory/conditioning | SLC12A6 CRHR1 STT3B SLC12A5 SLC6A3 SLC6A4 SLC6A7 PTCHD1 BRAF SLC16A3 SLC18A3 CLPTM1 MED25 PRKCG SLC16A7 SEZ6 | 6.36e-04 | 1239 | 74 | 16 | MP:0002063 |
| MousePheno | abnormal cognition | SLC12A6 CRHR1 STT3B SLC12A5 SLC6A3 SLC6A4 SLC6A7 PTCHD1 BRAF SLC16A3 SLC18A3 CLPTM1 MED25 PRKCG SLC16A7 SEZ6 | 6.77e-04 | 1246 | 74 | 16 | MP:0014114 |
| MousePheno | abnormal physiological response to xenobiotic | F2RL1 SLCO1B1 PTGS1 CCKBR SLCO1B7 SLC6A3 SLC6A4 SLC10A1 CLCNKB SLC47A1 DCLRE1A | 6.79e-04 | 662 | 74 | 11 | MP:0008872 |
| MousePheno | increased circulating bilirubin level | 7.48e-04 | 205 | 74 | 6 | MP:0005344 | |
| MousePheno | abnormal neurotransmitter uptake | 7.58e-04 | 8 | 74 | 2 | MP:0003444 | |
| MousePheno | impaired coordination | 9.10e-04 | 478 | 74 | 9 | MP:0001405 | |
| MousePheno | muscle hypertonia | 9.72e-04 | 9 | 74 | 2 | MP:0004143 | |
| MousePheno | abnormal parietal lobe morphology | 9.72e-04 | 37 | 74 | 3 | MP:0000794 | |
| Domain | G_PROTEIN_RECEP_F1_1 | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P OR5K3 OPN1SW F2RL1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 9.30e-12 | 685 | 100 | 22 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P OR5K3 OPN1SW F2RL1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 1.10e-11 | 691 | 100 | 22 | PS50262 |
| Domain | GPCR_Rhodpsn | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P OR5K3 OPN1SW F2RL1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 1.13e-11 | 692 | 100 | 22 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | VN1R4 OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 OR5K3 OPN1SW F2RL1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 4.68e-11 | 670 | 100 | 21 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 TRHR OR7C2 OR1S1 C5AR2 TAAR3P OR5K3 OPN1SW F2RL1 OR4K14 CCKBR OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 5.67e-11 | 677 | 100 | 21 | PF00001 |
| Domain | MFS_dom | SPNS1 SLCO1B1 SLCO6A1 SLC18B1 SLCO1B7 SLC16A3 SLC17A9 SLC18A3 SLC2A13 SLC16A7 | 2.58e-09 | 134 | 100 | 10 | IPR020846 |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 2.68e-09 | 393 | 100 | 15 | IPR000725 |
| Domain | MFS | SPNS1 SLCO1B1 SLC18B1 SLCO1B7 SLC16A3 SLC17A9 SLC18A3 SLC2A13 SLC16A7 | 6.33e-09 | 108 | 100 | 9 | PS50850 |
| Domain | NA_NEUROTRAN_SYMP_2 | 2.23e-06 | 18 | 100 | 4 | PS00754 | |
| Domain | SNF | 2.82e-06 | 19 | 100 | 4 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 2.82e-06 | 19 | 100 | 4 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 2.82e-06 | 19 | 100 | 4 | PS50267 | |
| Domain | Na/ntran_symport | 2.82e-06 | 19 | 100 | 4 | IPR000175 | |
| Domain | MFS_1 | 3.53e-06 | 77 | 100 | 6 | PF07690 | |
| Domain | MFS | 3.53e-06 | 77 | 100 | 6 | IPR011701 | |
| Domain | OA_transporter | 3.16e-05 | 12 | 100 | 3 | IPR004156 | |
| Domain | OATP | 3.16e-05 | 12 | 100 | 3 | PF03137 | |
| Domain | GPCR_2_EMR1-like_rcpt | 8.48e-05 | 3 | 100 | 2 | IPR001740 | |
| Domain | KCL_cotranspt | 1.69e-04 | 4 | 100 | 2 | IPR000076 | |
| Domain | AA-permease/SLC12A_dom | 2.13e-04 | 22 | 100 | 3 | IPR004841 | |
| Domain | AA_permease | 2.13e-04 | 22 | 100 | 3 | PF00324 | |
| Domain | Cyt_P450_CYP7A1-type | 2.81e-04 | 5 | 100 | 2 | IPR024204 | |
| Domain | Mtc | 2.81e-04 | 5 | 100 | 2 | PF03820 | |
| Domain | Mtc | 2.81e-04 | 5 | 100 | 2 | IPR004686 | |
| Domain | MCT | 2.81e-04 | 5 | 100 | 2 | IPR004743 | |
| Domain | SLC12A_fam | 5.86e-04 | 7 | 100 | 2 | IPR004842 | |
| Domain | SLC12_C | 7.78e-04 | 8 | 100 | 2 | IPR018491 | |
| Domain | SLC12 | 7.78e-04 | 8 | 100 | 2 | PF03522 | |
| Domain | GPCR_2_secretin-like_CS | 7.90e-04 | 34 | 100 | 3 | IPR017983 | |
| Domain | Kazal_2 | 9.35e-04 | 36 | 100 | 3 | PF07648 | |
| Domain | Ptc/Disp | 9.97e-04 | 9 | 100 | 2 | IPR003392 | |
| Domain | Patched | 9.97e-04 | 9 | 100 | 2 | PF02460 | |
| Domain | Cyt_P450_E_grp-IV | 1.24e-03 | 10 | 100 | 2 | IPR002403 | |
| Domain | SSD | 2.13e-03 | 13 | 100 | 2 | IPR000731 | |
| Domain | SSD | 2.13e-03 | 13 | 100 | 2 | PS50156 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.43e-03 | 50 | 100 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.43e-03 | 50 | 100 | 3 | PF00002 | |
| Domain | KAZAL_2 | 2.43e-03 | 50 | 100 | 3 | PS51465 | |
| Domain | Kazal_dom | 2.57e-03 | 51 | 100 | 3 | IPR002350 | |
| Domain | 7TM_GPCR_Srsx | 3.09e-03 | 112 | 100 | 4 | SM01381 | |
| Domain | C1_1 | 3.53e-03 | 57 | 100 | 3 | PF00130 | |
| Domain | SUGAR_TRANSPORT_2 | 3.66e-03 | 17 | 100 | 2 | PS00217 | |
| Domain | GPCR_2_secretin-like | 4.09e-03 | 60 | 100 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.09e-03 | 60 | 100 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.28e-03 | 61 | 100 | 3 | PS50261 | |
| Domain | ZF_DAG_PE_1 | 4.90e-03 | 64 | 100 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.90e-03 | 64 | 100 | 3 | PS50081 | |
| Domain | C1 | 5.12e-03 | 65 | 100 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 5.34e-03 | 66 | 100 | 3 | IPR002219 | |
| Domain | DAG/PE-bd | 5.58e-03 | 21 | 100 | 2 | IPR020454 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC26A9 SLCO1B1 SLC4A3 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC32A1 SLC6A7 SLC16A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 2.72e-13 | 238 | 80 | 16 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC26A9 SLCO1B1 SLC4A3 SLC12A5 SLC6A3 SLC7A8 SLC32A1 SLC6A7 SLC16A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 7.96e-12 | 249 | 80 | 15 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLCO1B1 SLC4A3 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC32A1 SLC6A7 TRPM5 SLC16A3 CLCNKB SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 1.17e-10 | 681 | 80 | 21 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 ATP6V0A1 ATP7B ABCC5 SLC26A9 SLCO1B1 SLC4A3 SLC12A5 SLC6A3 SLC7A8 SLC32A1 SLC6A7 TRPM5 SLC16A3 CLCNKB SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 3.20e-09 | 736 | 80 | 20 | M27287 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR4K14 OR9G9 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 1.04e-08 | 417 | 80 | 15 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OPN1SW OR4K14 OR9G9 OR1N2 OR2K2 TRPM5 OR52A5 OR7D2 OR52M1 MYO15A | 1.22e-08 | 636 | 80 | 18 | M41834 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC12A6 SLC26A9 SLC4A3 SLC12A5 SLC7A8 SLC32A1 SLC20A2 SLC6A20 | 1.68e-07 | 108 | 80 | 8 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC12A6 SLC26A9 SLC4A3 SLC12A5 SLC7A8 SLC32A1 SLC20A2 SLC6A20 | 1.80e-07 | 109 | 80 | 8 | MM15074 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.32e-07 | 76 | 80 | 7 | MM15072 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR4K14 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 2.60e-07 | 389 | 80 | 13 | M14091 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 4.63e-07 | 84 | 80 | 7 | M27334 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.30e-06 | 45 | 80 | 5 | MM14751 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | CYP8B1 ABCC5 SLCO1B1 SLC6A3 SLC6A4 SLC6A7 SLC10A1 SLC6A20 SLC2A13 | 6.96e-05 | 314 | 80 | 9 | M39428 |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.10e-04 | 44 | 80 | 4 | M499 | |
| Pathway | WP_NRF2_PATHWAY | 1.47e-04 | 141 | 80 | 6 | M39454 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.60e-04 | 19 | 80 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.60e-04 | 19 | 80 | 3 | MM15107 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 1.60e-04 | 19 | 80 | 3 | MM14612 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.45e-04 | 99 | 80 | 5 | M27474 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 3.02e-04 | 57 | 80 | 4 | M39812 | |
| Pathway | REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT | 4.70e-04 | 6 | 80 | 2 | MM17217 | |
| Pathway | REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT | 4.70e-04 | 6 | 80 | 2 | M27355 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDE7A TRHR RGS22 C5AR2 DGKG OPN1SW F2RL1 CRHR1 CCKBR ADGRE3 PRKCG ADGRE1 | 5.66e-04 | 702 | 80 | 12 | M746 |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 5.78e-04 | 29 | 80 | 3 | M45551 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.56e-04 | 7 | 80 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.56e-04 | 7 | 80 | 2 | MM15081 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 7.41e-04 | 126 | 80 | 5 | MM15553 | |
| Pathway | WP_GPCRS_NONODORANT | 7.73e-04 | 266 | 80 | 7 | MM15843 | |
| Pathway | REACTOME_NEUROTRANSMITTER_CLEARANCE | 8.71e-04 | 8 | 80 | 2 | MM14500 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDE7A TRHR C5AR2 TAAR3P DGKG OPN1SW F2RL1 CRHR1 CCKBR PRKCG ADGRE1 | 1.01e-03 | 646 | 80 | 11 | MM14962 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.25e-03 | 211 | 80 | 6 | MM14502 | |
| Pathway | REACTOME_NEUROTRANSMITTER_CLEARANCE | 1.69e-03 | 11 | 80 | 2 | M26914 | |
| Pathway | WP_GPCRS_OTHER | 1.91e-03 | 93 | 80 | 4 | M39629 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 2.02e-03 | 12 | 80 | 2 | M47597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 2.02e-03 | 12 | 80 | 2 | M47649 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 2.02e-03 | 12 | 80 | 2 | M48096 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 2.02e-03 | 12 | 80 | 2 | MM15476 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR1N2 OR2K2 OR52A5 OR52M1 | 6.72e-08 | 340 | 102 | 10 | 11875048 |
| Pubmed | OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR1N2 OR2K2 OR52A5 OR52M1 | 6.72e-08 | 340 | 102 | 10 | 11802173 | |
| Pubmed | OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR1N2 OR2K2 OR52A5 OR52M1 | 7.29e-08 | 343 | 102 | 10 | 32295537 | |
| Pubmed | OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR5K3 OR1N2 OR2K2 OR52A5 OR52M1 | 7.90e-08 | 346 | 102 | 10 | 14611657 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SPNS1 ATP6V0A1 GPAA1 C5AR2 F2RL1 SLC18B1 SLC4A3 CCKBR SLC12A5 SLC32A1 SLC20A2 CLPTM1 DCLRE1A | 1.37e-07 | 697 | 102 | 13 | 28298427 |
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 4.02e-07 | 21 | 102 | 4 | 16125675 | |
| Pubmed | Analysis of DNA methylation and histone modification profiles of liver-specific transporters. | 4.87e-07 | 6 | 102 | 3 | 19047482 | |
| Pubmed | OR5B3 OR4N2 OR9G1 OR7C2 OR1S1 OR4K14 OR1N2 OR2K2 OR52A5 OR7D2 OR52M1 | 5.80e-07 | 541 | 102 | 11 | 14983052 | |
| Pubmed | 6.98e-07 | 105 | 102 | 6 | 30280653 | ||
| Pubmed | Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons. | 8.50e-07 | 7 | 102 | 3 | 29337309 | |
| Pubmed | 8.50e-07 | 7 | 102 | 3 | 19844206 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 2.44e-06 | 130 | 102 | 6 | 19874574 | |
| Pubmed | 2.90e-06 | 10 | 102 | 3 | 18703564 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 11682476 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19176817 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25422958 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30419950 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 35508124 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12173460 | ||
| Pubmed | Treatment-resistant schizophrenia and DAT and SERT polymorphisms. | 8.52e-06 | 2 | 102 | 2 | 24680725 | |
| Pubmed | Genetic polymorphisms of serotonin and dopamine transporters in mental disorders. | 8.52e-06 | 2 | 102 | 2 | 12630565 | |
| Pubmed | Rapid purification and metabolomic profiling of synaptic vesicles from mammalian brain. | 8.52e-06 | 2 | 102 | 2 | 33043885 | |
| Pubmed | Ventral tegmental area GABA neurons mediate stress-induced blunted reward-seeking in mice. | 8.52e-06 | 2 | 102 | 2 | 34112787 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32693190 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17621383 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25640828 | ||
| Pubmed | A neurochemical approach to valuation sensitivity over gains and losses. | 8.52e-06 | 2 | 102 | 2 | 19726478 | |
| Pubmed | Neuron-type-specific signals for reward and punishment in the ventral tegmental area. | 8.52e-06 | 2 | 102 | 2 | 22258508 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32538722 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17502341 | ||
| Pubmed | Serotonergic neurons signal reward and punishment on multiple timescales. | 8.52e-06 | 2 | 102 | 2 | 25714923 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18588943 | ||
| Pubmed | SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD). | 8.52e-06 | 2 | 102 | 2 | 16139170 | |
| Pubmed | Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease. | 8.52e-06 | 2 | 102 | 2 | 18973248 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11320258 | ||
| Pubmed | BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. | 8.52e-06 | 2 | 102 | 2 | 23941441 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26751713 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18831910 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20505557 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12707931 | ||
| Pubmed | mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib. | 8.52e-06 | 2 | 102 | 2 | 26284586 | |
| Pubmed | Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. | 8.52e-06 | 2 | 102 | 2 | 29880484 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27860344 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12658362 | ||
| Pubmed | Identification of a mammalian vesicular polyamine transporter. | 8.52e-06 | 2 | 102 | 2 | 25355561 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22454241 | ||
| Pubmed | Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding. | 8.52e-06 | 2 | 102 | 2 | 34118233 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23527493 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 9636213 | ||
| Pubmed | Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. | 8.52e-06 | 2 | 102 | 2 | 15148564 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27425420 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25019689 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16604301 | ||
| Pubmed | The Raphe Dopamine System Controls the Expression of Incentive Memory. | 8.52e-06 | 2 | 102 | 2 | 32145184 | |
| Pubmed | Imaging genetics for utility of risks over gains and losses. | 8.52e-06 | 2 | 102 | 2 | 21801841 | |
| Pubmed | mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. | 8.52e-06 | 2 | 102 | 2 | 22549934 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18053732 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20739786 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20644949 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22138326 | ||
| Pubmed | Natural VTA activity during NREM sleep influences future exploratory behavior. | 8.52e-06 | 2 | 102 | 2 | 35663010 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19029042 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26984412 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22006250 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24439516 | ||
| Pubmed | RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth. | 8.52e-06 | 2 | 102 | 2 | 22797077 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29734780 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20029939 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22018085 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23717480 | ||
| Pubmed | BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas. | 8.52e-06 | 2 | 102 | 2 | 28879901 | |
| Pubmed | 1.09e-05 | 15 | 102 | 3 | 28112518 | ||
| Pubmed | 1.94e-05 | 18 | 102 | 3 | 31791063 | ||
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 1.94e-05 | 18 | 102 | 3 | 23696569 | |
| Pubmed | 2.27e-05 | 192 | 102 | 6 | 20602615 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 27045841 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 31047942 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 25422957 | ||
| Pubmed | Association of VNTR polymorphisms in DRD4, 5-HTT and DAT1 genes with obesity. | 2.55e-05 | 3 | 102 | 2 | 25687785 | |
| Pubmed | Ventral tegmental area glutamate neurons co-release GABA and promote positive reinforcement. | 2.55e-05 | 3 | 102 | 2 | 27976722 | |
| Pubmed | SLC6A3 (DAT1) as a Novel Candidate Biomarker Gene for Suicidal Behavior. | 2.55e-05 | 3 | 102 | 2 | 34199792 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24929324 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 39153478 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18296417 | ||
| Pubmed | Postingestive Modulation of Food Seeking Depends on Vagus-Mediated Dopamine Neuron Activity. | 2.55e-05 | 3 | 102 | 2 | 32259476 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 35896744 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 36351530 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 27733819 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 39019613 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19725049 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12401330 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22252133 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18492796 | ||
| Pubmed | Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. | 2.55e-05 | 3 | 102 | 2 | 28389619 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 29907857 | ||
| Pubmed | Serotonin transporter role in identifying similarities between SIDS and idiopathic ALTE. | 2.55e-05 | 3 | 102 | 2 | 22711722 | |
| Pubmed | Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics. | 2.55e-05 | 3 | 102 | 2 | 23986199 | |
| Pubmed | Precise Regulation of the Basal PKCγ Activity by DGKγ Is Crucial for Motor Coordination. | 2.55e-05 | 3 | 102 | 2 | 33114041 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20949553 | ||
| Pubmed | Distinct neural mechanisms for the prosocial and rewarding properties of MDMA. | 2.55e-05 | 3 | 102 | 2 | 31826983 | |
| Interaction | SLC32A1 interactions | 1.34e-05 | 11 | 89 | 3 | int:SLC32A1 | |
| Interaction | FXYD6-FXYD2 interactions | 1.68e-05 | 35 | 89 | 4 | int:FXYD6-FXYD2 | |
| Interaction | SLC12A7 interactions | 2.62e-05 | 132 | 89 | 6 | int:SLC12A7 | |
| Cytoband | 11p15.4 | 5.70e-06 | 200 | 101 | 6 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 3.67e-05 | 564 | 101 | 8 | chr11p15 | |
| GeneFamily | Solute carriers | SLC12A6 SLC26A9 SLCO1B1 SLCO6A1 SLC18B1 SLC4A3 SLC25A51 SLC12A5 SLCO1B7 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC10A1 SLC16A3 SLC17A9 SLC18A3 SLC20A2 SLC6A20 SLC47A1 SLC2A13 SLC16A7 | 1.38e-19 | 395 | 82 | 23 | 752 |
| GeneFamily | Sideroflexins | 2.01e-04 | 5 | 82 | 2 | 746 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 2.01e-04 | 5 | 82 | 2 | 915 | |
| GeneFamily | Olfactory receptors, family 9 | 4.83e-03 | 23 | 82 | 2 | 156 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 193 | 99 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 193 | 99 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 193 | 99 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| Computational | Genes in the cancer module 218. | 2.35e-08 | 20 | 49 | 5 | MODULE_218 | |
| Computational | Peptide and AA transporters. | 1.11e-06 | 18 | 49 | 4 | MODULE_368 | |
| Computational | Genes in the cancer module 162. | 1.40e-06 | 19 | 49 | 4 | MODULE_162 | |
| Computational | Membranal receptors. | ATP7B SLC4A3 GFRA3 CCKBR SLC6A3 SLC6A4 SLC6A7 SLC10A1 SLC16A3 SLC18A3 ADGRE1 | 1.58e-05 | 517 | 49 | 11 | MODULE_64 |
| Drug | sodium | SLC12A6 SPNS1 ATP7B SLC26A9 SLCO1B1 SLC4A3 PTGS1 SLC12A5 SLC6A3 SLC7A8 SLC6A4 SLC32A1 SLC6A7 SLC10A1 TRPM5 CLCNKB MTOR SLC18A3 SLC20A2 SLC6A20 SLC47A1 PRKCG SLC2A13 UEVLD | 2.50e-12 | 944 | 101 | 24 | CID000000923 |
| Drug | His-pro-dkp | 2.41e-07 | 31 | 101 | 5 | CID000065137 | |
| Drug | cimetidine | 1.35e-06 | 179 | 101 | 8 | CID000002756 | |
| Drug | 3 MMA | 1.68e-06 | 6 | 101 | 3 | CID000130136 | |
| Drug | sulfinpyrazone | 2.48e-06 | 87 | 101 | 6 | CID000005342 | |
| Drug | tauroursocholate | 4.01e-06 | 146 | 101 | 7 | CID000005246 | |
| Drug | bumetanide | SLC12A6 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC10A1 CLCNKB SLC20A2 | 4.29e-06 | 209 | 101 | 8 | CID000002471 |
| Drug | tri-n-butylmethylammonium | 4.67e-06 | 8 | 101 | 3 | CID000036208 | |
| Drug | chloride | SLC12A6 ATP7B RNPC3 SLC26A9 SLC4A3 PTGS1 SLC12A5 SLC6A3 SLC6A4 SLC32A1 SLC6A7 BRAF CLCNKB SLC18A3 SLC20A2 SLC6A20 | 1.16e-05 | 1029 | 101 | 16 | CID000000312 |
| Drug | Piperazines | 1.36e-05 | 11 | 101 | 3 | ctd:D010879 | |
| Drug | euflavine | 1.72e-05 | 35 | 101 | 4 | CID000091561 | |
| Drug | 5-mm AI | 1.81e-05 | 12 | 101 | 3 | CID000131575 | |
| Drug | probenecid | 1.83e-05 | 123 | 101 | 6 | CID000004911 | |
| Drug | Sertraline | 1.95e-05 | 2 | 101 | 2 | DB01104 | |
| Drug | methylcyanoformate | 1.95e-05 | 2 | 101 | 2 | CID000028660 | |
| Drug | N-Nor-cit | 1.95e-05 | 2 | 101 | 2 | CID000131993 | |
| Drug | dichloropane | 1.95e-05 | 2 | 101 | 2 | CID000127024 | |
| Drug | 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane | 1.95e-05 | 2 | 101 | 2 | ctd:C069723 | |
| Drug | benzhydryl ether | 1.95e-05 | 2 | 101 | 2 | CID000011323 | |
| Drug | quinelorane | 2.15e-05 | 37 | 101 | 4 | CID000057242 | |
| Drug | sipatrigine | 2.15e-05 | 37 | 101 | 4 | CID000060803 | |
| Drug | Bile Acids and Salts | 2.70e-05 | 79 | 101 | 5 | ctd:D001647 | |
| Drug | AC1L9NAZ | 2.92e-05 | 198 | 101 | 7 | CID000449606 | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 5542_UP | |
| Drug | desvenlafaxine | 3.26e-05 | 41 | 101 | 4 | CID000125017 | |
| Drug | Cephalothin | 3.71e-05 | 15 | 101 | 3 | ctd:D002512 | |
| Drug | sodium ferulate | 4.55e-05 | 88 | 101 | 5 | CID000000709 | |
| Drug | Bumetanide | 4.55e-05 | 16 | 101 | 3 | ctd:D002034 | |
| Drug | amoxapine | 5.16e-05 | 46 | 101 | 4 | CID000002170 | |
| Drug | Tyramine | 5.51e-05 | 17 | 101 | 3 | ctd:D014439 | |
| Drug | D-161 compound | 5.83e-05 | 3 | 101 | 2 | ctd:C532102 | |
| Drug | Mazindol | 5.83e-05 | 3 | 101 | 2 | DB00579 | |
| Drug | Methylphenidate | 5.83e-05 | 3 | 101 | 2 | DB00422 | |
| Drug | Duloxetine | 5.83e-05 | 3 | 101 | 2 | DB00476 | |
| Drug | 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | 5.83e-05 | 3 | 101 | 2 | ctd:C569113 | |
| Drug | Venlafaxine | 5.83e-05 | 3 | 101 | 2 | DB00285 | |
| Drug | 4-fluoroamphetamine | 5.83e-05 | 3 | 101 | 2 | ctd:C040639 | |
| Drug | Sibutramine | 5.83e-05 | 3 | 101 | 2 | DB01105 | |
| Drug | RTI-219 | 5.83e-05 | 3 | 101 | 2 | CID010524711 | |
| Drug | 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine | 5.83e-05 | 3 | 101 | 2 | ctd:C079321 | |
| Drug | 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | 5.83e-05 | 3 | 101 | 2 | ctd:C000592273 | |
| Drug | difluoropine | 5.83e-05 | 3 | 101 | 2 | CID000190851 | |
| Drug | Dexmethylphenidate | 5.83e-05 | 3 | 101 | 2 | DB06701 | |
| Drug | 2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine | 5.83e-05 | 3 | 101 | 2 | ctd:C000595926 | |
| Drug | 1,4-diazabicyclo[3.3.1]nonane | 5.83e-05 | 3 | 101 | 2 | CID015140257 | |
| Drug | 99mTc-NC100697 | 5.83e-05 | 3 | 101 | 2 | CID016066474 | |
| Drug | NBD-Chol | 5.83e-05 | 3 | 101 | 2 | CID000133523 | |
| Drug | 5-(2-aminopropyl)benzofuran | 5.83e-05 | 3 | 101 | 2 | ctd:C000608250 | |
| Drug | 4-methoxymethamphetamine | 5.83e-05 | 3 | 101 | 2 | ctd:C060169 | |
| Drug | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 5.83e-05 | 3 | 101 | 2 | ctd:C554181 | |
| Drug | Imipenem | 6.59e-05 | 18 | 101 | 3 | ctd:D015378 | |
| Drug | sodium cholate | CYP8B1 ABCC5 CYP39A1 SLCO1B1 PTGS1 CCKBR SLC10A1 SCARB2 NPC1L1 | 8.52e-05 | 408 | 101 | 9 | CID000000303 |
| Drug | 3-Hydroxy-3-methylglutaryl Coenzyme A | 1.01e-04 | 104 | 101 | 5 | CID015983953 | |
| Drug | (24R)-Cholest-5-ene-3-beta,7-alpha,24-triol | 1.16e-04 | 4 | 101 | 2 | CID011430046 | |
| Drug | Fluorescent Dyes | 1.16e-04 | 4 | 101 | 2 | ctd:D005456 | |
| Drug | Chlorpheniramine | 1.16e-04 | 4 | 101 | 2 | DB01114 | |
| Drug | bicyclo[3.2.1]octane | 1.16e-04 | 4 | 101 | 2 | CID000260716 | |
| Drug | benzylpiperidine | 1.16e-04 | 4 | 101 | 2 | CID000076190 | |
| Drug | O 526 | 1.16e-04 | 4 | 101 | 2 | CID003025846 | |
| Drug | AC1L2OZT | 1.16e-04 | 4 | 101 | 2 | CID000125682 | |
| Drug | Biogenic Monoamines | 1.16e-04 | 4 | 101 | 2 | ctd:D015306 | |
| Drug | 4-(4-Chlorophenyl)piperidine | 1.16e-04 | 4 | 101 | 2 | CID001203613 | |
| Drug | butriptyline | 1.16e-04 | 4 | 101 | 2 | CID000021771 | |
| Drug | indatraline | 1.16e-04 | 4 | 101 | 2 | ctd:C418119 | |
| Drug | Cyclic AMP | 1.17e-04 | 247 | 101 | 7 | ctd:D000242 | |
| Drug | estrone sulfate | 1.41e-04 | 23 | 101 | 3 | ctd:C017296 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 1.57e-04 | 61 | 101 | 4 | CID000003868 | |
| Drug | bisphenol F | 1.60e-04 | 24 | 101 | 3 | ctd:C000611646 | |
| Drug | Eo-B | 1.82e-04 | 25 | 101 | 3 | CID009547937 | |
| Drug | vinyl sulfoxide | 1.93e-04 | 5 | 101 | 2 | CID000014217 | |
| Drug | Phentermine | 1.93e-04 | 5 | 101 | 2 | DB00191 | |
| Drug | [11c]afe | 1.93e-04 | 5 | 101 | 2 | CID005732447 | |
| Drug | [11c]afa | 1.93e-04 | 5 | 101 | 2 | CID005352128 | |
| Drug | [11c]afm | 1.93e-04 | 5 | 101 | 2 | CID005352125 | |
| Drug | Mazindol | 1.93e-04 | 5 | 101 | 2 | ctd:D008454 | |
| Drug | Nomifensine | 1.93e-04 | 5 | 101 | 2 | ctd:D009627 | |
| Drug | Neomycin | 2.05e-04 | 26 | 101 | 3 | ctd:D009355 | |
| Drug | furosemide | 2.13e-04 | 272 | 101 | 7 | CID000003440 | |
| Drug | NO-711 | 2.13e-04 | 66 | 101 | 4 | CID000004515 | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | 2.23e-04 | 193 | 101 | 6 | 4118_UP | |
| Drug | BBCH | 2.29e-04 | 27 | 101 | 3 | CID000115288 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 2208_DN | |
| Drug | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine | 2.53e-04 | 69 | 101 | 4 | CID000003172 | |
| Drug | sodium glycocholate | 2.53e-04 | 69 | 101 | 4 | CID000000755 | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 2651_DN | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 2882_DN | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 3814_UP | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 5783_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 2392_UP | |
| Drug | H-8105 | 2.65e-04 | 282 | 101 | 7 | CID000164531 | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 2453_DN | |
| Drug | Pilocarpine | 2.82e-04 | 285 | 101 | 7 | ctd:D010862 | |
| Drug | Anilino | 2.85e-04 | 29 | 101 | 3 | CID000137550 | |
| Drug | AC1L9NDJ | 2.89e-04 | 6 | 101 | 2 | CID000449667 | |
| Drug | Escitalopram | 2.89e-04 | 6 | 101 | 2 | DB01175 | |
| Drug | naphthalene-1,5-disulfonate | 2.89e-04 | 6 | 101 | 2 | CID000006666 | |
| Drug | P-13 | 2.89e-04 | 6 | 101 | 2 | CID000017955 | |
| Drug | Potassium Chloride | 2.89e-04 | 6 | 101 | 2 | DB00761 | |
| Drug | [11c]sa4503 | 2.89e-04 | 6 | 101 | 2 | CID009820591 | |
| Drug | LY288513 | 2.89e-04 | 6 | 101 | 2 | CID000132190 | |
| Disease | Allodynia | 7.46e-06 | 84 | 94 | 5 | C0458247 | |
| Disease | Mechanical Allodynia | 7.46e-06 | 84 | 94 | 5 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 7.46e-06 | 84 | 94 | 5 | C0751212 | |
| Disease | Hyperalgesia, Primary | 7.46e-06 | 84 | 94 | 5 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 7.46e-06 | 84 | 94 | 5 | C0751214 | |
| Disease | Tactile Allodynia | 7.46e-06 | 84 | 94 | 5 | C0751213 | |
| Disease | Hyperalgesia | 7.46e-06 | 84 | 94 | 5 | C0020429 | |
| Disease | Anxiety States, Neurotic | 1.19e-05 | 44 | 94 | 4 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 1.19e-05 | 44 | 94 | 4 | C1279420 | |
| Disease | Anxiety Disorders | 1.19e-05 | 44 | 94 | 4 | C0003469 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 4.98e-05 | 63 | 94 | 4 | DOID:3083 (is_implicated_in) | |
| Disease | pancreatic cancer (implicated_via_orthology) | 6.00e-05 | 4 | 94 | 2 | DOID:1793 (implicated_via_orthology) | |
| Disease | Anhedonia | 6.04e-05 | 24 | 94 | 3 | C0178417 | |
| Disease | Cocaine Dependence | 8.46e-05 | 139 | 94 | 5 | C0600427 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 9.68e-05 | 28 | 94 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | X-23756 measurement | 9.98e-05 | 5 | 94 | 2 | EFO_0022126 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 9.98e-05 | 5 | 94 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | nicotine dependence (is_implicated_in) | 1.49e-04 | 6 | 94 | 2 | DOID:0050742 (is_implicated_in) | |
| Disease | Obsessive-Compulsive Disorder | 1.49e-04 | 6 | 94 | 2 | C0028768 | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 3.56e-04 | 9 | 94 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.56e-04 | 9 | 94 | 2 | EFO_0800562 | |
| Disease | gamma-glutamylthreonine measurement | 4.44e-04 | 10 | 94 | 2 | EFO_0021143 | |
| Disease | octadecanedioate measurement | 4.44e-04 | 10 | 94 | 2 | EFO_0021056 | |
| Disease | cholestasis (biomarker_via_orthology) | 5.19e-04 | 49 | 94 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Cocaine-Related Disorders | 5.44e-04 | 117 | 94 | 4 | C0236736 | |
| Disease | Malignant neoplasm of breast | ATP7B LAMA2 DGKG SLCO1B1 PTGS1 SLC25A51 CRHR1 SLC6A3 BRAF SLC16A3 MTOR | 6.18e-04 | 1074 | 94 | 11 | C0006142 |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 6.49e-04 | 12 | 94 | 2 | C1861063 | |
| Disease | Cocaine Abuse | 7.40e-04 | 127 | 94 | 4 | C0009171 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 7.65e-04 | 13 | 94 | 2 | EFO_0800474 | |
| Disease | Withdrawal Symptoms | 8.51e-04 | 58 | 94 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 8.51e-04 | 58 | 94 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 8.51e-04 | 58 | 94 | 3 | C0038587 | |
| Disease | Alcohol abuse | 1.29e-03 | 67 | 94 | 3 | C0085762 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.66e-03 | 19 | 94 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 1.68e-03 | 538 | 94 | 7 | C0678222 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 1.84e-03 | 20 | 94 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | HbA1c measurement, response to sulfonylurea | 2.03e-03 | 21 | 94 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | Mood Disorders | 2.08e-03 | 168 | 94 | 4 | C0525045 | |
| Disease | Involutional paraphrenia | 2.87e-03 | 25 | 94 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 2.87e-03 | 25 | 94 | 2 | C1571984 | |
| Disease | Involutional Depression | 2.87e-03 | 25 | 94 | 2 | C0011574 | |
| Disease | Intellectual Disability | 3.10e-03 | 447 | 94 | 6 | C3714756 | |
| Disease | Lymphatic Metastasis | 3.10e-03 | 26 | 94 | 2 | C0024232 | |
| Disease | pseudotumor cerebri | 3.10e-03 | 26 | 94 | 2 | EFO_1001132 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFGIVLYELMTGQLP | 641 | P15056 | |
| PLAVLFGIFLYMGVT | 1106 | P48751 | |
| QSGGKIFPQYVLMFG | 686 | Q6P2P2 | |
| ALFYPATFGIVGQKM | 391 | Q9H981 | |
| YNLVGIPIAAGVFMP | 1331 | P35670 | |
| PSMFYVGLFFVNVLI | 26 | O95424 | |
| LFFIPGVVMAVAYGL | 226 | P32239 | |
| MAFYPLQIAGLVLGF | 1 | P56750 | |
| FTTDPGMQLGLFVVF | 16 | Q8NH87 | |
| GMQLGLFVVFLGVYS | 21 | Q8NH87 | |
| IGLAIMLTGVPVYFL | 451 | Q9UHI5 | |
| PSGLGGFVVFYVVLM | 656 | O75427 | |
| FVLFLGMYLVTVIGN | 41 | Q8NH92 | |
| FIVMQSVFYPAGRIS | 201 | Q5T9C9 | |
| SRFVSIGLYMPAVGF | 366 | O43292 | |
| LYIPGFDVGTMFTIQ | 211 | P61550 | |
| YAVAASVMVLGLFVP | 231 | O15427 | |
| GSILVSVNPYQMFGI | 1256 | Q9UKN7 | |
| YFIPSTVGVVLFMTG | 306 | Q63HM2 | |
| IPFSAMYLIGVIGNS | 31 | Q9H2C5 | |
| FFGVYVAIMLGNLLI | 31 | Q8NGD5 | |
| ITHIIVIFFMFGPGI | 241 | Q8NGD1 | |
| VGIFYGTIIFMYLQP | 246 | Q8NH48 | |
| NIQIGFMTYLVEPLF | 411 | Q13946 | |
| LSGNVIMFLGFFAPI | 251 | O60669 | |
| IFMGLIPYDQSGFVN | 521 | Q71SY5 | |
| VVGMLYVGGLPINYT | 2881 | P24043 | |
| FGVLLYEMLAGQPPF | 541 | P05129 | |
| MLKRGIFVIGFSYPV | 366 | O75600 | |
| FFAIYLITMVGNIGL | 31 | A6NET4 | |
| MGQIIPIYGFGIFLY | 96 | Q7Z5B4 | |
| ITTFFLVGMPGLEYA | 11 | Q8NGJ7 | |
| ITTFFLVGMPGLEYA | 11 | Q8NGJ6 | |
| FTTDPGMQLGLFVVF | 16 | P0C7N8 | |
| GMQLGLFVVFLGVYS | 21 | P0C7N8 | |
| VGQEVFGLLPGLMLY | 286 | P23219 | |
| SILYVPAVYGGNVVM | 1191 | P42694 | |
| VAQYGIMPLTAFVLG | 66 | Q14973 | |
| FYLGQMPGSLVLIII | 276 | Q9UHC9 | |
| VYTIVFVVGLPSNGM | 81 | P55085 | |
| LGMIYNVIILGPTGF | 306 | O15440 | |
| FLEGIAILNIPSMYG | 651 | P49619 | |
| PLIGEYLVFTMIFVT | 311 | P30532 | |
| LYAAIFLVGVPGNAM | 41 | Q9P296 | |
| AYLGLIGTAMTPNFV | 291 | O60609 | |
| LLGITYMLFFVNPGE | 351 | P34998 | |
| MGVVLYEFLVGCVPF | 566 | O60307 | |
| ARIKYGPIFTVFAMG | 56 | Q9NYL5 | |
| GAVMILFYLPNGTVI | 796 | Q6PJP8 | |
| SMVNFYIVALPLAVG | 101 | Q8N4W6 | |
| GTFMGVYLPCLQNIF | 186 | Q9UHW9 | |
| IAINVFSIMYTGAPV | 191 | Q08357 | |
| QLGGQYFTFVMDPLS | 71 | Q9UNU6 | |
| NIVMYFVTIVLGVFP | 196 | O60412 | |
| GTFMGVYLPCLQNIF | 121 | Q9H2X9 | |
| LVGIYFPSVTGIMAG | 426 | Q9H2X9 | |
| QPLLFGIFLGMYLVT | 41 | Q8NGR9 | |
| PGLEVVLFVFSLVMY | 21 | Q8NGT1 | |
| LQAAFMGTVFLIGFP | 36 | P03999 | |
| IPFGSMYLVAVVGNV | 31 | Q8NGK5 | |
| TLLMYTVPAVQGFFR | 1876 | P42345 | |
| MLGLAAVPAVIQFFG | 241 | Q96QE2 | |
| FFTPGSIMVGIYGKI | 206 | Q9P1P4 | |
| YDVPLLIGLGVMFAS | 151 | Q16572 | |
| LPGGMIITGFMLQFY | 96 | Q96NB2 | |
| TFLGVIPQFVQMKYG | 176 | Q6P4A7 | |
| FGVFYVVPMILATVL | 196 | P34981 | |
| LLTYFFLGGVHQMVP | 111 | Q7LBE3 | |
| LMQAGFILYRPVSGY | 171 | Q5T9Z0 | |
| FNLPAGYVGLVFLGM | 266 | Q6NT16 | |
| LGPYVFREAQMTIFG | 1111 | Q8NE09 | |
| MYLVTFGIGASPFTN | 381 | Q96NR3 | |
| LGAMLGFLFFPINVV | 221 | Q9H1U9 | |
| SMVGYVLGPFFLITL | 16 | Q86T20 | |
| IAGMPLYILGITFID | 241 | Q86UG4 | |
| TNIPYIIMALGVFFG | 436 | Q14108 | |
| ILMGLLQGVYFPALT | 126 | Q9BYT1 | |
| STLIYFMTGVLGVFP | 196 | Q96RA2 | |
| LPAVAIGMFSGGYII | 336 | G3V0H7 | |
| GSFLVPYIIMLIVEG | 41 | Q9NP91 | |
| ITIPIFASGMFLGGY | 381 | Q9Y6L6 | |
| IFSVLGYMSQELGVP | 341 | Q99884 | |
| LAIIVYMVPAGFSVA | 301 | Q96FL8 | |
| YYVVGLPIGIALMFA | 416 | Q96FL8 | |
| QYPFVLGLVMAVVFS | 186 | Q8IWX5 | |
| FGYGLPMLVVVISAS | 716 | Q14246 | |
| FQIGPVAGVMAYLFT | 816 | Q14246 | |
| QVGPAAQVMAYLFTI | 571 | Q9BY15 | |
| LYGFLLTFGFITMTP | 511 | O96005 | |
| FMPIFVYGAAIGRLF | 426 | P51801 | |
| ANGYVLFGKPMVVQF | 486 | Q96LT9 | |
| PVTVFLGNVVMYFAF | 731 | Q9NZQ8 | |
| QDLPLNIYMVIFGTG | 31 | Q9H9V4 | |
| TFYIVGLILSMQIPF | 296 | Q8TCJ2 | |
| YALVPVFFIMGLFGV | 61 | Q8IUW5 | |
| RMLSIFYFAIPVGSG | 186 | Q9H2V7 | |
| GAFLVPYLLFMVIAG | 96 | Q01959 | |
| SLFYMLVEFVVGQLP | 211 | Q6IQ55 | |
| YGLAFMVILPVVVGS | 196 | Q9UGP8 | |
| FLPLVAMVLLVGGVY | 931 | Q53EL9 | |
| NPMVQLFYGTFLTEG | 286 | Q96RU2 | |
| GVPQTMAAFGVRYFL | 61 | Q7Z5H5 | |
| GLYDFPQRQVMVGSF | 16 | O43151 | |
| LNIYFGFIPEIIFMT | 566 | Q93050 | |
| GFIPEIIFMTSLFGY | 571 | Q93050 | |
| DLLNFTGTIPVMYQG | 51 | Q8IX04 | |
| TNAIQGMFVLGLPYA | 126 | Q9H598 | |
| AFLLPYTIMAIFGGI | 116 | P31645 |